animal model also revealed that G9a knockdown would decrease tumor growth. We discovered that DUSP4 was upregulated in G9a-downregulated HNSCC cells and the expression level of phospho-ERK was inhibited. DUSP4 expression could also be inhibited after treatment with BIX-01294 in HNSCC cells.
Objective: Determine the significant parameters of PET/CT in the prediction of the nature of lung lesions during the staging of newly diagnosed or recurrent oral cavity cancer.
Method:
We retrospectively reviewed the charts of 183 patients from July 2010 to December 2011 with newly diagnosed or recurrent oral cavity cancer. Twelve cases with positive PET/CT lung lesions (SUVmax >4) subsequently underwent biopsy. The SUVmax, number of lesion, and side were studied.
Results: A total of 12 patients were collected as suspicious for lung metastases. One case with esophageal cancer was excluded. Five were lung metastases, 3 were second primary lung cancer, and the remaining 3 were chronic inflammation. Comparing with second primary and chronic inflammation, metastases had higher SUVmax but without significant difference (P value >.05). Metastases and chronic inflammation had higher incidence of multifocal lesions comparing with second primary (P value, metastases vs second primary: .008, chronic inflammation vs second primary: .09). There is no significant difference between the metastases and chronic inflammation (P value: .38). For side and lesion, no significance was noted.
Conclusion: Based on our preliminary data, higher SUVmax value (mean: lung metastases: 6.65, second primary lung cancer: 3.96, chronic inflammation: 3.98) and multifocal lesions favor metastatic lung lesions compared with second primary or chronic inflammation.
Head and Neck Surgery the transfusion Dilemma in Free tissue transfer
Scott M. Greene, MD (presenter); Ross L. Shockley; Sarah L. Rohde, MD Objective: Despite the NIH recommendation for transfusions based on the individual patient, many microvascular surgeons continue to use a trigger point to guide transfusion criteria in patients undergoing free tissue transfer. Our objective is to learn the effects of blood transfusion on complications in free tissue transfer patients.
Method: A retrospective study of patients undergoing free tissue transfer with and without blood transfusions from June 2005 through May 2011 at a single tertiary care center. Outcome measurements include flap failure, hematoma, fistula rate, respiratory failure and cardiovascular events.
Results: A total of 225 patients underwent free tissue transfer during the study period. One hundred twenty-one patients received either intraoperative or postoperative blood products. When compared to a group of 100 patients similar in age, BMI and pre/post-operative hematocrit levels, there was a statically significant difference in total hospital length of stay (7.8 vs 9.5 days, P = .01) and total rate of complications (9 vs 33.8%, P = .0002). Specific post-operative complication rates were as follows; flap failure (2% vs 5.7% failure rate), respiratory failure (0 vs 12.6% patients required prolonged ventilatory support), and hematoma rates of 2% and 12%, respectively.
Conclusion:
For patients undergoing free tissue transfer, transfusion of blood products is associated with a statistically significant increase in postoperative morbidity. We propose basing transfusion criteria on an individual basis rather than by means of a trigger point.
